Reference Source

Huazhong Pharmaceutical Co., Ltd · 66-66 · CHINA

For Huazhong Pharmaceutical Co., Ltd · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product code is 65 J - - 31 Progesterone (Progestin); date published is 09/30/2009; address is No 71 West Chunyuan Road , Xiangyang, Hubei CHINA, verified against its source on 2026-09-16.

Firm
Huazhong Pharmaceutical Co., Ltd verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
CHINA verified
Address
No 71 West Chunyuan Road , Xiangyang, Hubei CHINA verified
Date published
09/30/2009 verified
Product code
65 J - - 31 Progesterone (Progestin) verified
FDA notes
10/10/2000 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Huazhong Pharmaceutical Co., Ltd Date Published : 09/30/2009 No 71 West Chunyuan Road , Xiangyang, Hubei CHINA 65 J - - 31 Progesterone (Progestin) Date Published: 09/30/2009 Notes: 10/10/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.